查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1607134

G 蛋白偶联受体市场：按产品类型、检测类型、应用划分 - 2025-2030 年全球预测

G-Protein Coupled Receptors Market by Product (Cell Culture Reagents, Cell Lines, Detection Kits), Assay Type (Calcium Functional Assays, cAMP Functional Assays, Internalization Assays), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年G蛋白偶联受体市场价值为33.1亿美元，预计2024年将达到35.1亿美元，复合年增长率为6.27%，2030年将达到50.7亿美元，预计将达到1000万美元。

G 蛋白偶联受体 (GPCR) 是一个庞大的细胞表面受体家族，在许多生理过程中都很重要，这使得它们对于药物发现和开发至关重要。 GPCR市场范围涵盖製药、生物技术和学术领域，其在癌症、心血管疾病和神经系统疾病等多种疾病的治疗中发挥重要作用。高通量筛检技术和先进的计算模型能够更精确地定位和理解 GPCR 功能，从而增强在药物发现和个人化医疗中的应用。最终用途领域主要包括製药公司、研究机构和受託研究机构。市场成长主要由慢性病盛行率上升、研发投资增加以及基因组学和蛋白​​质组学技术进步所推动。 GPCR 研究与人工智慧和机器学习的整合为更具预测性和针对性的治疗提供了机会，为个人化医疗和新颖的治疗方法铺平了道路。儘管有这些机会，市场仍面临高成本、复杂的监管要求以及理解 GPCR 结构的技术限制等挑战。此外，激烈的竞争和对专业人员的需求也阻碍了成长。克服这些障碍的策略包括学术界和工业界的共同努力、增加对基础研究的资助以及培育技术共用的伙伴关係。基于结构的药物设计和变构调节的创新是有前景的业务成长领域。总体而言，GPCR 市场正在蓬勃发展，全面了解受体功能对于挖掘其潜力至关重要。优先考虑创新、策略联盟和适应性监管环境的公司可能会在这个不断变化的环境中获得显着的利益。

主要市场统计
基准年[2023] 33.1亿美元
预测年份 [2024] 35.1亿美元
预测年份 [2030] 50.7亿美元
复合年增长率（%） 6.27%

市场动态：快速发展的 G 蛋白偶联受体市场的关键市场洞察

G 蛋白偶联受体市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球心血管疾病增加
    • 增加开发新药物和治疗方法的支出
    • 正在进行的减轻癌症负担的研究工作
  • 市场限制因素
    • G 蛋白偶联受体 (GPCR) 相关的高成本
  • 市场机会
    • 核准的新药和治疗方法数量迅速增加
    • G蛋白偶联受体分子认识新进展
  • 市场挑战
    • 缺乏经过训练的专业人员和受过训练的受试者的专业知识，加上严格的核准标准

波特五力：驾驭 G 蛋白偶联受体市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 G 蛋白偶联受体市场的外部影响

外部宏观环境因素在塑造 G 蛋白偶联受体市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解G蛋白偶联受体市场的竞争格局

G 蛋白偶联受体市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵G蛋白偶联受体市场供应商绩效评估

FPNV 定位矩阵是评估 G 蛋白偶联受体市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製 G 蛋白偶联受体市场的成功之路

G 蛋白偶联受体市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病在世界范围内呈上升趋势
      • 增加开发新药物和治疗方法的支出
      • 正在进行的减轻癌症负担的研究活动
    • 抑制因素
      • G 蛋白偶联受体 (GPCR) 相关的高成本
    • 机会
      • 新药和新治疗方法的监管核准迅速增加
      • G蛋白偶联受体分子认识新进展
    • 任务
      • 缺乏熟练的专业人员和训练有素的主题专业知识以及严格的核准标准
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 G蛋白偶联受体市场：副产品

  • 细胞培养试剂
  • 细胞株
  • 检测试剂套件
  • 配体

第 7 章按检测类型分類的 G 蛋白偶联受体市场

  • 钙功能测定
  • cAMP功能测定
  • 内化分析
  • 放射性配体结合和 GTPYS 功能测定
  • 运输分析
  • B-抑制蛋白功能测定

第八章 G蛋白偶联受体市场：依应用分类

  • 癌症研究
  • 心血管检查
  • 中枢神经系统检查
  • 发炎检查
  • 代谢研究
  • 呼吸道检查

第九章 美洲G蛋白偶联受体市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太G蛋白偶联受体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲G蛋白偶联受体市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abalone Bio, Inc.
  • Abcam PLC
  • Addex Therapeutics
  • Becton, Dickinson and Company
  • BioInvenu,Inc.
  • Cisbio Bioassays SAS
  • Confo Therapeutics
  • Corning Incorporated
  • Crinetics Pharmaceuticals, Inc.
  • Domain Therapeutics SA
  • Enzo Life Sciences, Inc.
  • Escient Pharmaceuticals
  • Eurofins Scientific SE
  • Merck KGaA
  • Molecular Devices, LLC
  • OKYO Pharma, Limited
  • Orion Biotechnology
  • OSE Immunotherapeutics
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN GmbH
  • Septerna
  • Sosei Group Corporation
  • Tectonic Therapeutic
  • Teon Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
Product Code: MRR-521BAA36EDBA

The G-Protein Coupled Receptors Market was valued at USD 3.31 billion in 2023, expected to reach USD 3.51 billion in 2024, and is projected to grow at a CAGR of 6.27%, to USD 5.07 billion by 2030.

G-Protein Coupled Receptors (GPCRs) are a vast family of cell surface receptors crucial in many physiological processes, making them vital in drug discovery and development. The GPCR market's scope encompasses pharmaceuticals, biotechnology, and the academic sector, necessitated by its role in treating a wide array of diseases such as cancer, cardiovascular disorders, and neurological conditions. The high-throughput screening techniques and advanced computational modeling have enabled more precise targeting and understanding of GPCR functions, thereby enhancing applications in drug discovery and personalized medicine. End-use segments mainly include pharmaceutical companies, research institutions, and contract research organizations. Market growth is primarily driven by the rising prevalence of chronic diseases, increasing investment in research and development, and technological advancements in genomics and proteomics. The integration of artificial intelligence and machine learning with GPCR research offers opportunities for more predictive and targeted therapies, paving the way for personalized medicine and novel therapeutic approaches. Despite these opportunities, the market faces challenges such as high costs associated with R&D, complex regulatory requirements, and technical limitations in understanding GPCR structures. Moreover, the high competition and need for specialized personnel can also impede growth. Strategies to overcome these obstacles include collaborative efforts between academia and industry, increased funding for basic research, and fostering partnerships for technology sharing. Innovations in structure-based drug design and allosteric modulation represent promising areas for business growth. Overall, the GPCR market is dynamic and expanding, with a comprehensive understanding of receptor functions being integral to harnessing its potential. Companies that prioritize innovation, strategic collaborations, and adaptive regulatory strategies stand to benefit significantly in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 3.31 billion
Estimated Year [2024] USD 3.51 billion
Forecast Year [2030] USD 5.07 billion
CAGR (%) 6.27%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving G-Protein Coupled Receptors Market

The G-Protein Coupled Receptors Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of cardiovascular diseases across the globe
    • Increasing expenditure for the development of novel pharmaceutical drugs and therapies
    • Ongoing research activities to reduce the cancer burden
  • Market Restraints
    • Associated high cost with G-protein coupled receptors (GPCRs)
  • Market Opportunities
    • Surge in the number of regulatory approvals for novel drugs and therapies
    • Emerging advances in the molecular understanding of G protein-coupled receptors
  • Market Challenges
    • Lack of skilled professionals or trained subject expertise coupled with stringent approval norms

Porter's Five Forces: A Strategic Tool for Navigating the G-Protein Coupled Receptors Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the G-Protein Coupled Receptors Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the G-Protein Coupled Receptors Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the G-Protein Coupled Receptors Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the G-Protein Coupled Receptors Market

A detailed market share analysis in the G-Protein Coupled Receptors Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the G-Protein Coupled Receptors Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the G-Protein Coupled Receptors Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the G-Protein Coupled Receptors Market

A strategic analysis of the G-Protein Coupled Receptors Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the G-Protein Coupled Receptors Market, highlighting leading vendors and their innovative profiles. These include Abalone Bio, Inc., Abcam PLC, Addex Therapeutics, Becton, Dickinson and Company, BioInvenu,Inc., Cisbio Bioassays SAS, Confo Therapeutics, Corning Incorporated, Crinetics Pharmaceuticals, Inc., Domain Therapeutics SA, Enzo Life Sciences, Inc., Escient Pharmaceuticals, Eurofins Scientific SE, Merck KGaA, Molecular Devices, LLC, OKYO Pharma, Limited, Orion Biotechnology, OSE Immunotherapeutics, PerkinElmer Inc., Promega Corporation, QIAGEN GmbH, Septerna, Sosei Group Corporation, Tectonic Therapeutic, Teon Therapeutics, Inc., Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the G-Protein Coupled Receptors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cell Culture Reagents, Cell Lines, Detection Kits, and Ligands.
  • Based on Assay Type, market is studied across Calcium Functional Assays, cAMP Functional Assays, Internalization Assays, Radioligand Binding and GTPYS Functional Assays, Trafficking Assays, and B-Arrestin Functional Assays.
  • Based on Application, market is studied across Cancer Research, Cardiovascular Research, CNS Research, Inflammation Research, Metabolic Research, and Respiratory Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of cardiovascular diseases across the globe
      • 5.1.1.2. Increasing expenditure for the development of novel pharmaceutical drugs and therapies
      • 5.1.1.3. Ongoing research activities to reduce the cancer burden
    • 5.1.2. Restraints
      • 5.1.2.1. Associated high cost with G-protein coupled receptors (GPCRs)
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in the number of regulatory approvals for novel drugs and therapies
      • 5.1.3.2. Emerging advances in the molecular understanding of G protein-coupled receptors
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals or trained subject expertise coupled with stringent approval norms
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. G-Protein Coupled Receptors Market, by Product

  • 6.1. Introduction
  • 6.2. Cell Culture Reagents
  • 6.3. Cell Lines
  • 6.4. Detection Kits
  • 6.5. Ligands

7. G-Protein Coupled Receptors Market, by Assay Type

  • 7.1. Introduction
  • 7.2. Calcium Functional Assays
  • 7.3. cAMP Functional Assays
  • 7.4. Internalization Assays
  • 7.5. Radioligand Binding and GTPYS Functional Assays
  • 7.6. Trafficking Assays
  • 7.7. B-Arrestin Functional Assays

8. G-Protein Coupled Receptors Market, by Application

  • 8.1. Introduction
  • 8.2. Cancer Research
  • 8.3. Cardiovascular Research
  • 8.4. CNS Research
  • 8.5. Inflammation Research
  • 8.6. Metabolic Research
  • 8.7. Respiratory Research

9. Americas G-Protein Coupled Receptors Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific G-Protein Coupled Receptors Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa G-Protein Coupled Receptors Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abalone Bio, Inc.
  • 2. Abcam PLC
  • 3. Addex Therapeutics
  • 4. Becton, Dickinson and Company
  • 5. BioInvenu,Inc.
  • 6. Cisbio Bioassays SAS
  • 7. Confo Therapeutics
  • 8. Corning Incorporated
  • 9. Crinetics Pharmaceuticals, Inc.
  • 10. Domain Therapeutics SA
  • 11. Enzo Life Sciences, Inc.
  • 12. Escient Pharmaceuticals
  • 13. Eurofins Scientific SE
  • 14. Merck KGaA
  • 15. Molecular Devices, LLC
  • 16. OKYO Pharma, Limited
  • 17. Orion Biotechnology
  • 18. OSE Immunotherapeutics
  • 19. PerkinElmer Inc.
  • 20. Promega Corporation
  • 21. QIAGEN GmbH
  • 22. Septerna
  • 23. Sosei Group Corporation
  • 24. Tectonic Therapeutic
  • 25. Teon Therapeutics, Inc.
  • 26. Thermo Fisher Scientific Inc.
  • 27. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. G-PROTEIN COUPLED RECEPTORS MARKET RESEARCH PROCESS
  • FIGURE 2. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. G-PROTEIN COUPLED RECEPTORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. G-PROTEIN COUPLED RECEPTORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. G-PROTEIN COUPLED RECEPTORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. G-PROTEIN COUPLED RECEPTORS MARKET DYNAMICS
  • TABLE 7. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CELL CULTURE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DETECTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LIGANDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CALCIUM FUNCTIONAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CAMP FUNCTIONAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY INTERNALIZATION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RADIOLIGAND BINDING AND GTPS FUNCTIONAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY TRAFFICKING ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY B-ARRESTIN FUNCTIONAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CNS RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY INFLAMMATION RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY METABOLIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RESPIRATORY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. G-PROTEIN COUPLED RECEPTORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 154. G-PROTEIN COUPLED RECEPTORS MARKET, FPNV POSITIONING MATRIX, 2023